<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.756641</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Di Rosa</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/84240"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cossarizza</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hayday</surname>
<given-names>Adrian C.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Molecular Biology and Pathology, National Research Council of Italy (CNR)</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia</institution>, <addr-line>Modena</addr-line>, <country>Italy</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>National Institute for Cardiovascular Research</institution>, <addr-line>Bologna</addr-line>, <country>Italy</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Immunosurveillance Laboratory, The Francis Crick Institute</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Peter Gorer Department of Immunobiology, King&#x2019;s College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>National Institute for Health Research (NIHR) Biomedical Research Center (BRC), Guy&#x2019;s and St Thomas&#x2019; NHS Foundation Trust and King&#x2019;s College London</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and reviewed by: Pablo Engel, University of Barcelona, Spain</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Francesca Di Rosa, <email xlink:href="mailto:francesca.dirosa@cnr.it">francesca.dirosa@cnr.it</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>756641</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Di Rosa, Cossarizza and Hayday</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Di Rosa, Cossarizza and Hayday</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fimmu.2021.653974" ext-link-type="doi">A Corrigendum on <article-title>To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis</article-title> By Di Rosa F, Cossarizza A and Hayday AC (2021). Front. Immunol. 12:653974. doi:&#xa0;<object-id>10.3389/fimmu.2021.653974</object-id>. </related-article>
<kwd-group>
<kwd>flow cytometry</kwd>
<kwd>T cells</kwd>
<kwd>cell cycle</kwd>
<kwd>Ki-67</kwd>
<kwd>DNA dye</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="845"/>
</counts>
</article-meta>
</front>
<body>
<p>In the original article, there was a mistake in the legend for <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref> as published. On the Viable cells, no &#x201c;dump&#x201d; gate, &#x201c;CD16&#x201d; was written instead of &#x201c;CD19&#x201d;. The correct legend appears below.</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>Example of CD8 T cell na&#xef;ve/memory subset analysis by T<sub>DS</sub> assay. HD PBMCs were stained with the viability dye eFluor 780 (eF780), the DNA dye Hoechst-33342, and fluorochrome conjugated mAbs against surface markers and Ki-67, as described (16). An example of flow cytometry analysis is shown. <bold>(A)</bold> Gating of viable single CD8 T cells in 6 steps: 1) DNA-A/-W singlets. Single cells having 2n&#x2264; DNA content &#x2264;4n were selected on the DNA-area (A) <italic>versus</italic> (<italic>vs</italic>) DNA-width (W) plot; 2) Time exclusion. Stable acquisition over time (seconds) was monitored on the time <italic>vs</italic> DNA-A plot and any events collected in case of pressure fluctuations were excluded; 3) Viable cells, no &#x201c;dump&#x201d;. Cells expressing CD4, CD14 and CD19, and dead cells were excluded; 4) FSC A/SSC-A &#x201c;relaxed&#x201d; gate. A &#x201c;relaxed gate was used on the FSC-A <italic>vs</italic> SSC-A plot, to include highly activated and cycling lymphocytes (15); 5) CD8 T cells. CD8 T cells were gated on the CD3 <italic>versus</italic> CD8 plot; 6) Refined singlets. A few remaining doublets composed by one cell sitting on top of another (so called &#x201c;shadow&#x201d; doublets) were excluded as Ki-67int/<sup>-</sup> events having &gt; 2n DNA content (16). This gating strategy was used as a base for the subsequent gates. <bold>(B)</bold> The following na&#xef;ve/memory subsets of CD8 T cells were identified: CD45RA<sup>+</sup> CCR <sup>+</sup> Na&#xef;ve, CD45RA<sup>-</sup> CCR7<sup>+</sup> central memory (CM), CD45RA<sup>-</sup> CCR7<sup>-</sup> effector memory (EM), and CD45RA<sup>+</sup> CCR7<sup>-</sup> (EMRA). <bold>(C)</bold> Cell cycle phases of each na&#xef;ve/memory CD8 T cell subset were defined on DNA-A <italic>vs</italic> Ki67-A plot as follows: cells in G<sub>0</sub> were identified as DNA 2n/Ki67<sup>-</sup> (bottom left quadrant); cells in G<sub>1</sub> as DNA 2n/Ki67<sup>+</sup> (upper left quadrant); cells in S-G2/M (or TDS cells) as DNA&gt;2n/Ki67<sup>+</sup> (top right quadrant). Unpublished data in relation to (16).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-756641-g001.tif"/>
</fig>
<p><bold>&#x201c;</bold>HD PBMCs were stained with the viability dye eFluor 780 (eF780), the DNA dye Hoechst-33342, and fluorochrome conjugated mAbs against surface markers and Ki-67, as described (16). An example of flow cytometry analysis is shown. <bold>(A)</bold> Gating of viable single CD8 T cells in 6 steps: 1) DNA-A/-W singlets. Single cells having 2n&#x2264; DNA content &#x2264;4n were selected on the DNA-area (A) <italic>versus (vs)</italic> DNA-width (W) plot; 2) Time exclusion. Stable acquisition over time (seconds) was monitored on the time <italic>vs</italic> DNA-A plot and any events collected in case of pressure fluctuations were excluded; 3) Viable cells, no &#x201c;dump&#x201d;. Cells expressing CD4, CD14 and CD19, and dead cells were excluded; 4) FSC-A/SSC-A &#x201c;relaxed&#x201d; gate. A &#x201c;relaxed&#x201d; gate was used on the FSC-A <italic>vs</italic> SSC-A plot, to include highly activated and cycling lymphocytes (15); 5) CD8 T cells. CD8 T cells were gated on the CD3 <italic>versus</italic> CD8 plot; 6) Refined singlets. A few remaining doublets composed by one cell sitting on top of another (so called &#x201c;shadow&#x201d; doublets) were excluded as Ki-67<sup>int</sup>/<sup>-</sup> events having &gt; 2n DNA content (16). This gating strategy was used as a base for the subsequent gates. <bold>(B)</bold> The following na&#xef;ve/memory subsets of CD8 T cells were identified: CD45RA<sup>+</sup> CCR7<sup>+</sup> Na&#xef;ve, CD45RA<sup>-</sup> CCR7<sup>+</sup> central memory (CM), CD45RA<sup>-</sup> CCR7<sup>-</sup> effector memory (EM), and CD45RA<sup>+</sup> CCR7<sup>-</sup> (EMRA). <bold>(C)</bold> Cell cycle phases of each na&#xef;ve/memory CD8 T cell subset were defined on DNA-A <italic>vs</italic> Ki67-A plot as follows: cells in G<sub>0</sub> were identified as DNA 2n/Ki67<sup>-</sup> (bottom left quadrant); cells in G<sub>1</sub> as DNA 2n/Ki67<sup>+</sup> (upper left quadrant); cells in S-G<sub>2</sub>/M (or T<sub>DS</sub> cells) as DNA&gt;2n/Ki67<sup>+</sup> (top right quadrant). Unpublished data in relation to (16).&#x201d;</p>
<p>In the original article, there was also a mistake in the legend for <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table 1</bold>
</xref> as published. The peptide- HLA-A*02 tetramer list was incorrectly formatted, there was missing information about numbers in the table (they represent average percentages); missing information about the number of mice (panel A) and number of human donors (panel B and C); and a missing citation of original references at the end. The corrected <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material File</bold>
</xref> is linked below.</p>
<p>In the original article, there was also a mistake in <bold>Figure&#xa0;1</bold> as published. <bold>There was an incorrect y-axis label in panel A, third graph from left.</bold> The corrected <bold>Figure&#xa0;1</bold> appears below.</p>
<p>The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.</p>
<sec id="s1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s2" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.756641/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2021.756641/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
</back>
</article>